Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-25T02:13:30.308Z Has data issue: false hasContentIssue false
  • English
  • Français

Metabolic syndrome or glucose challenge in first episode of psychosis?

Published online by Cambridge University Press:  03 February 2017

C. Garcia-Rizo ,
E. Fernandez-Egea ,
C. Oliveira ,
A. Meseguer ,
B. Cabrera ,
G. Mezquida ,
M. Bioque ,
R. Penades ,
E. Parellada  and
M. Bernardo
...Show all authors
C. Garcia-Rizo*
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain Institute of Biomedical Research Agusti Pi i Sunyer (IDIBAPS), Barcelona, Spain
E. Fernandez-Egea
Affiliation:
Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain Department of Psychiatry, University of Cambridge, Addenbrooke's HospitalCB2 0QQCambridge, UK Cambridgeshire and Peterborough NHS Foundation Trust, PE29 3RJHuntingdon, UK
C. Oliveira
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain
A. Meseguer
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain
B. Cabrera
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain
G. Mezquida
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain
M. Bioque
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain
R. Penades
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain Institute of Biomedical Research Agusti Pi i Sunyer (IDIBAPS), Barcelona, Spain Department of Medicine, University of Barcelona, Barcelona, Spain
E. Parellada
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain Institute of Biomedical Research Agusti Pi i Sunyer (IDIBAPS), Barcelona, Spain Department of Medicine, University of Barcelona, Barcelona, Spain
M. Bernardo
Affiliation:
Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic, Barcelona, Spain Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain Institute of Biomedical Research Agusti Pi i Sunyer (IDIBAPS), Barcelona, Spain Department of Medicine, University of Barcelona, Barcelona, Spain
B. Kirkpatrick
Affiliation:
Department of Psychiatry and Behavioral Sciences, University of Nevada School of Medicine, Reno, Nevada, USA
*
⁎Corresponding author. Barcelona Clinic Schizophrenia Unit, Villarroel 170, 08036 Barcelona, Spain. Tel.: +34932275547; fax: +3432275548. E-mail address: cgarcia3@clinic.ub.es (C. Garcia-Rizo).
Get access

Abstract

Patients with schizophrenia exhibit a reduced life expectancy. Although unhealthy lifestyle or suicide risk plays a role, the main causes are diverse medical conditions such as cardiovascular diseases, type 2 diabetes mellitus and metabolic syndrome. Albeit pharmacological secondary side effects might also trigger previous conditions, studies in naïve patients reflect diverse anomalies at the onset. Patients with a first episode of psychosis, display a wide scope of metabolic abnormalities, ranging from normality till pathological values depending on the parameters studied. We attempted to evaluate the metabolic syndrome and glycemic homeostasis in a subset of antipsychotic-naïve patients with a first episode of non-affective psychosis. Patients (n = 84) showed a similar prevalence of metabolic syndrome compared with a matched control sample (n = 98) (6% vs 4%, P = 0.562), while glucose homeostasis values differed significantly (14% vs. 5%, P = 0.034). Our results suggest that metabolic syndrome is not a useful clinical condition to be evaluated in patients before pharmacological treatment. Abnormal glycemic homeostasis at the onset of the disease requires specific diagnostic tools and preventive measures in order to avoid future cardiovascular events. New strategies must be implemented in order to evaluate the cardiovascular risk and subsequent morbidity in patients at the onset of the disease.

Keywords

Metabolic syndromeOral glucose tolerance testFirst episodePsychosisAntipsychotic-naïveThrifty psychiatric phenotype
Type
Original article
Information
European Psychiatry , Volume 41 , Issue 1 , March 2017 , pp. 42 - 46
Copyright
Copyright © European Psychiatric Association 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Laursen, T.M.Nordentoft, M.Mortensen, P.B.Excess early mortality in schizophrenia. Annu Rev Clin Psychol 2014;10:425–448. http://dx.doi.org/10.1146/annurev-clinpsy-032813-153657.CrossRefGoogle Scholar
Zipursky, R.B.Why are the outcomes in patients with schizophrenia so poor?. J Clin Psychiatry 2014;75(Suppl. 2):20–24. http://dx.doi.org/10.4088/JCP.13065su1.05.CrossRefGoogle ScholarPubMed
Brown, S.Birtwistle, J.Roe, L.Thompson, C.The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29:697–701.CrossRefGoogle ScholarPubMed
Wise, J.Schizophrenia is associated with increased rates of violence and suicide, Swedish study finds. BMJ 2014;348:g3690. http://dx.doi.org/10.1136/bmj.g3690.CrossRefGoogle ScholarPubMed
Koola, M.M.McMahon, R.P.Wehring, H.J.Liu, F.Mackowick, K.M.Warren, K.R.et al.Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders. J Psychiatr Res 2012;46:987–993. http://dx.doi.org/10.1016/j.jpsychires.2012.04.019S0022-3956(12)00133-1. [pii].CrossRefGoogle ScholarPubMed
Arango, C.Bobes, J.Aranda, P.Carmena, R.Garcia-Garcia, M.Rejas, J.A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study. Schizophr Res 2008;104:1–12. http://dx.doi.org/10.1016/j.schres.2008.05.009S0920-9964(08)00236-3. [pii].CrossRefGoogle ScholarPubMed
Chen, S.F.Hu, T.M.Lan, T.H.Chiu, H.J.Sheen, L.Y.Loh, E.W.Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: severe negative syndrome may be related to a distinct lipid pathophysiology. Eur Psychiatry 2014;29:167–171. http://dx.doi.org/10.1016/j.eurpsy.2013.04.003S0924-9338(13)00054-0. [pii].CrossRefGoogle ScholarPubMed
Association ADAPAAA of CENAA for the S of O. Consensus development conference on antipsychotic drugs and obesity. Diabetes Care 2004;27:596–601. http://dx.doi.org/10.2337/diacare.27.2.596.CrossRefGoogle Scholar
Saiz-Ruiz, J.Saiz-Gonzalez, M.D.Alegria, A.A.Mena, E.Luque, J.Bobes, J.[Impact of the spanish consensus on physical health of patients with schizophrenia]. Rev Psiquiatr Salud Ment 2010;3:119–127. http://dx.doi.org/10.1016/j.rpsm.2010.11.001S1888-9891(10)00075-3. [pii].CrossRefGoogle Scholar
Sáiz, Ruiz JBobes García, JVallejo Ruiloba, JGiner Ubago, J, García-Portilla González MP. [Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry]. Actas Esp Psiquiatr 2008;36(5):251–64.Google Scholar
De Hert, M.Vancampfort, D.Correll, C.U.Mercken, V.Peuskens, J.Sweers, K.et al.Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry 2011;199:99–105. http://dx.doi.org/10.1192/bjp.bp.110.084665.CrossRefGoogle ScholarPubMed
Kaur, J.A comprehensive review on metabolic syndrome. Cardiol Res Pr 2014;2014:943162. http://dx.doi.org/10.1155/2014/943162.Google ScholarPubMed
Shin, J.A.Lee, J.H.Lim, S.Y.Ha, H.S.Kwon, H.S.Park, Y.M.et al.Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig 2013;4:334–343. http://dx.doi.org/10.1111/jdi.12075JDI12075. [pii].CrossRefGoogle ScholarPubMed
Alberti, K.G.Zimmet, P.Shaw, J.The metabolic syndrome--a new worldwide definition. Lancet 2005;366:1059–1062. [doi:S0140-6736(05)67402-8 [pii]10.1016/S0140-6736(05)67402-8].CrossRefGoogle ScholarPubMed
Grundy, S.M.Cleeman, J.I.Daniels, S.R.Donato, K.A.Eckel, R.H.Franklin, B.A.et al.Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–2752. [doi:CIRCULATIONAHA.105.169404 [pii]10.1161/CIRCULATIONAHA.105.169404].CrossRefGoogle ScholarPubMed
McEvoy, J.P.Meyer, J.M.Goff, D.C.Nasrallah, H.A.Davis, S.M.Sullivan, L.et al.Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005;80:19–32. [doi:S0920-9964(05)00310-5 [pii]10.1016/j.schres.2005.07.014].CrossRefGoogle ScholarPubMed
Allison, D.B.Casey, D.E.Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 2001;62(Suppl. 7:22–31.Google ScholarPubMed
Fernandez-Egea, E.Miller, B.Garcia-Rizo, C.Bernardo, M.Kirkpatrick, B.Metabolic effects of olanzapine in patients with newly diagnosed psychosis. J Clin Psychopharmacol 2011;31:154–159. http://dx.doi.org/10.1097/JCP.0b013e31820fcea3.CrossRefGoogle ScholarPubMed
Arango, C.Giraldez, M.Merchan-Naranjo, J.Baeza, I.Castro-Fornieles, J.Alda, J.A.et al.Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naive patients. J Am Acad Child Adolesc Psychiatry 2014;53 [1179-1190, 1190e1-4, doi:S0890-8567(14)00583-8 [pii]10.1016/j.jaac.2014.08.009].CrossRefGoogle ScholarPubMed
Mitchell, A.J.Vancampfort, D.Sweers, K.van Winkel, R.Yu, W.De Hert, M.Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. Schizophr Bull 2013;39:306–318. http://dx.doi.org/10.1093/schbul/sbr148.CrossRefGoogle ScholarPubMed
Bartoli, F.Crocamo, C.Caslini, M.Clerici, M.Carrà, G.Schizoaffective disorder and metabolic syndrome: a meta-analytic comparison with schizophrenia and other non-affective psychoses. J Psychiatr Res 2015;66:127–134. http://dx.doi.org/10.1016/j.jpsychires.2015.04.028.CrossRefGoogle ScholarPubMed
Patel, J.K.Buckley, P.F.Woolson, S.Hamer, R.M.McEvoy, J.P.Perkins, D.O.et al.Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res 2009;111:9–16. http://dx.doi.org/10.1016/j.schres.2009.03.025S0920-9964(09)00124-8. [pii].CrossRefGoogle ScholarPubMed
Padmavati, R.McCreadie, R.G.Tirupati, S.Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia. Schizophr Res 2010;121:199–202. http://dx.doi.org/10.1016/j.schres.2010.05.010S0920-9964(10)01306-X. [pii].CrossRefGoogle ScholarPubMed
Saddichha, S.Ameen, S.Akhtar, S.Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patients. Schizophr Res 2007;95:247. [doi:S0920-9964(07)00249-6 [pii]10.1016/j.schres.2007.05.036].CrossRefGoogle ScholarPubMed
De Hert, M.Schreurs, V.Sweers, K.Van Eyck, D.Hanssens, L.Sinko, S.et al.Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. Schizophr Res 2008;101:295–303. http://dx.doi.org/10.1016/j.schres.2008.01.028S0920-9964(08)00093-5. [pii].CrossRefGoogle ScholarPubMed
Grover, S.Aggarwal, M.Chakrabarti, S.Dutt, A.Avasthi, A.Kulhara, P.et al.Prevalence of metabolic syndrome in bipolar disorder: an exploratory study from North India. Prog Neuropsychopharmacol Biol Psychiatry 2012;36:141–146. http://dx.doi.org/10.1016/j.pnpbp.2011.10.013S0278-5846(11)00310-1. [pii].CrossRefGoogle ScholarPubMed
Pallava, A.Chadda, R.K.Sood, M.Lakshmy, R.Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naive and antipsychotic-treated patients from India. Nord J Psychiatry 2012;66:215–221. http://dx.doi.org/10.3109/08039488.2011.621977.CrossRefGoogle ScholarPubMed
Mitchell, A.J.Vancampfort, D.De Herdt, A.Yu, W.De Hert, M.Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia?. A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull 2013;39:295–305. http://dx.doi.org/10.1093/schbul/sbs082sbs082. [pii].CrossRefGoogle ScholarPubMed
McIntyre, R.S.Mancini, D.A.Pearce, M.M.Silverstone, P.Chue, P.Misener, V.L.et al.Mood and psychotic disorders and type 2 diabetes: a metabolic triad. Can J Diabetes 2005;29:122–132.Google Scholar
Suvisaari, J.Partti, K.Perala, J.Viertio, S.Saarni, S.E.I.Lonnqvist, J.et al.Mortality and its determinants in people with psychotic disorder. Psychosom Med 2013;75:60–67. http://dx.doi.org/10.1097/PSY.0b013e31827ad512PSY.0b013e31827ad512 [pii].CrossRefGoogle ScholarPubMed
Fernandez-Egea, E.Garcia-Rizo, C.Zimbron, J.Kirkpatrick, B.Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view. Schizophr Bull 2013;39:266–267. http://dx.doi.org/10.1093/schbul/sbs134sbs134. [pii].CrossRefGoogle ScholarPubMed
Chen, Y.T.Mukherjee, J.J.Lee, C.H.Au, V.S.Tavintharan, S.Comparing fasting plasma glucose against two-hour post-load glucose concentrations for the diagnosis of diabetes mellitus and glucose intolerance in Singaporean hospital patients. Ann Acad Med Singapore 2002;31:189–194.Google Scholar
Fernandez-Egea, E.Bernardo, M.Donner, T.Conget, I.Parellada, E.Justicia, A.et al.Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry 2009;194:434–438. http://dx.doi.org/10.1192/bjp.bp.108.052605.CrossRefGoogle ScholarPubMed
Kirkpatrick, B.Miller, B.J.Garcia-Rizo, C.Fernandez-Egea, E.Bernardo, M.Is abnormal glucose tolerance in antipsychotic-na??ve patients with nonaffective psychosis confounded by poor health habits?. Schizophr Bull 2012;38:280–284. http://dx.doi.org/10.1093/schbul/sbq058.CrossRefGoogle ScholarPubMed
Garcia-Rizo, C.Kirkpatrick, B.Fernandez-Egea, E.Oliveira, C.Bernardo, M.Abnormal glycemic homeostasis at the onset of serious mental illnesses: a common pathway. Psychoneuroendocrinology 2016;67:70–75. http://dx.doi.org/10.1016/j.psyneuen.2016.02.001.CrossRefGoogle ScholarPubMed
Haffner, S.M.Miettinen, H.Stern, M.P.The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087–1092.CrossRefGoogle ScholarPubMed
Guallar-Castillon, P.Perez, R.F.Lopez Garcia, E.Leon-Munoz, L.M.Aguilera, M.T.Graciani, A.et al.Magnitude and management of metabolic syndrome in Spain in 2008-2010: the ENRICA study. Rev Esp Cardiol (Engl Ed) 2014;67:367–373. http://dx.doi.org/10.1016/j.rec.2013.08.014S1885-5857(13)00315-0. [pii].CrossRefGoogle Scholar
Padmanabhan, J.L.Nanda, P.Tandon, N.Mothi, S.S.Bolo, N.Mccarroll, S.et al.Polygenic risk for type 2 diabetes mellitus among individuals with. J Psychiatr Res 2016;77:52–8. http://dx.doi.org/10.1016/j.jpsychires.2016.02.015. [Epub 2016 Feb 23]CrossRefGoogle ScholarPubMed
Bonora, E.Formentini, G.Calcaterra, F.Lombardi, S.Marini, F.Zenari, L.et al.HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:1135–1141. http://dx.doi.org/10.2337/diacare.25.7.1135.CrossRefGoogle ScholarPubMed
Zhang, X.Y.Chen, D.-C.Tan, Y.-L.An, H.-M.Zunta-Soares, G.B.Huang, X.-F.et al.Glucose disturbances in first-episode drug-naïve schizophrenia: relationship to psychopathology. Psychoneuroendocrinology 2015;62:376–380. http://dx.doi.org/10.1016/j.psyneuen.2015.09.005.CrossRefGoogle ScholarPubMed
Petrikis, P.Tigas, S.Tzallas, A.T.Papadopoulos, I.Skapinakis, P.Mavreas, V.Parameters of glucose and lipid metabolism at the fasted state in drug-naïve first-episode patients with psychosis: evidence for insulin resistance. Psychiatry Res 2015;229:901–904. http://dx.doi.org/10.1016/j.psychres.2015.07.041.CrossRefGoogle ScholarPubMed
Dasgupta, A.Singh, O.P.Rout, J.K.Saha, T.Mandal, S.Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1202–1207. http://dx.doi.org/10.1016/j.pnpbp.2010.06.011.CrossRefGoogle ScholarPubMed
Chen, S.Broqueres-You, D.Yang, G.Wang, Z.Li, Y.Wang, N.et al.Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia. Psychiatry Res 2013;210:825–829. http://dx.doi.org/10.1016/j.psychres.2013.08.056.CrossRefGoogle ScholarPubMed
Gayoso-Diz, P.Otero-González, A.Rodriguez-Alvarez, M.X.Gude, F.García, F.De Francisco, A.et al.Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 2013;13:47. http://dx.doi.org/10.1186/1472-6823-13-47.CrossRefGoogle Scholar
Garcia-Rizo, C.Kirkpatrick, B.Fernandez-Egea, E.Oliveira, C.Meseguer, A.Grande, I.et al.“Is bipolar disorder an endocrine condition?” Glucose abnormalities in bipolar disorder. Acta Psychiatr Scand 2014. http://dx.doi.org/10.1111/acps.12194.CrossRefGoogle ScholarPubMed
Garcia-Rizo, C.Fernandez-Egea, E.Miller, B.J.Oliveira, C.Justicia, A.Griffith, J.K.et al.Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-na??ve patients with depression. Brain Behav Immun 2013;28:49–53. http://dx.doi.org/10.1016/j.bbi.2012.11.009.CrossRefGoogle ScholarPubMed
Nordentoft, M.Wahlbeck, K.Hallgren, J.Westman, J.Osby, U.Alinaghizadeh, H.et al.Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 2013;8:e55176. http://dx.doi.org/10.1371/journal.pone.0055176PONE-D-12-26455. [pii].CrossRefGoogle ScholarPubMed
Garcia-Rizo, C.Fernandez-Egea, E.Bernardo, M.Kirkpatrick, B.The thrifty psychiatric phenotype. Acta Psychiatr Scand 2015;131:18–20. http://dx.doi.org/10.1111/acps.12309.CrossRefGoogle ScholarPubMed
Suvisaari, J.M.Taxell-Lassas, V.Pankakoski, M.Haukka, J.K.Lonnqvist, J.K.Hakkinen, L.T.Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull 2012. [doi:sbs109 [pii]10.1093/schbul/sbs109].Google ScholarPubMed
Matheson, S.L.Shepherd, A.M.Laurens, K.R.Carr, V.J.A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res 2011;133:133–142. [doi:S0920-9964(11)00499-3 [pii]10.1016/j.schres.2011.09.020].CrossRefGoogle ScholarPubMed
Brown, A.S.Susser, E.S.Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull 2008;34:1054–1063. http://dx.doi.org/10.1093/schbul/sbn096sbn096.[pii].CrossRefGoogle ScholarPubMed
Varese, F.Smeets, F.Drukker, M.Lieverse, R.Lataster, T.Viechtbauer, W.et al.Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 2012;38:661–671. [doi:sbs050 [pii]10.1093/schbul/sbs050].CrossRefGoogle ScholarPubMed
Bernardo, M.Bioque, M.Parellada, M.Ruiz, J.S.Cuesta, M.J.Llerena, A.et al.Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs). Rev Psiquiatr Y Salud Ment (English Ed) 2013;6:4–16. http://dx.doi.org/10.1016/j.rpsmen.2012.11.001.Google Scholar
Harley, M.Kelleher, I.Clarke, M.Lynch, F.Arseneault, L.Connor, D.et al.Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol Med 2010;40:1627–1634. http://dx.doi.org/10.1017/S0033291709991966S0033291709991966. [pii].CrossRefGoogle ScholarPubMed
Pilgaard, K.Faerch, K.Carstensen, B.Poulsen, P.Pisinger, C.Pedersen, O.et al.Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia 2010;53:2526–2530. http://dx.doi.org/10.1007/s00125-010-1917-3.CrossRefGoogle Scholar
Pacheco-Lopez, G.Giovanoli, S.Langhans, W.Meyer, U.Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. Schizophr Bull 2011;39:319–329. [doi:sbr178 [pii]10.1093/schbul/sbr178].CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.